Going from technology to biology to fix babies' hearts

Clinicians at the Mayo Clinic and Boston Children's Hospital are among those attempting to harness the body's own regenerative power to treat babies born with one ventricle, a condition known as hypoplastic left heart syndrome. Surgical advances over the past three decades have enabled some children with the condition to survive, but many others do not. At Boston Children's, blood flow is being surgically restored to the left ventricle in an effort to spur regeneration, while teams at Mayo are using the babies' umbilical-cord blood cells to strengthen the right ventricle enough to compensate for loss of the left.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA